Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids.
William C Stanley; Ramzi J Khairallah; Erinne R Dabkowski (Profiled Author: William C Stanley)
Division of Cardiology, Department of Medicine, University of Maryland, Baltimore, Maryland 21201, USA. wstanley@medicine.umaryland.edu
Current opinion in clinical nutrition and metabolic care 2012;15(2):122-6.
PURPOSE OF REVIEW: Recent evidence has linked n-3 polyunsaturated fatty acid (PUFA) supplementation with dramatic alterations of mitochondrial phospholipid membranes and favorable changes in mitochondrial function. In the present review, we examine the novel effects of n-3 PUFA on mitochondria, with an emphasis on cardiac mitochondrial phospholipids. RECENT FINDINGS: There is growing evidence that dietary n-3 PUFA, particularly docosahexaenoic acid (DHA), has profound effects on mitochondrial membrane phospholipid composition and mitochondrial function. Supplementation with n-3 PUFA increases membrane phospholipid DHA and depletes arachidonic acid, and can increase cardiolipin, a tetra-acyl phospholipid that is unique to mitochondrial and essential for optimal mitochondrial function. Recent studies show that supplementation with DHA decreases propensity for cardiac mitochondria to undergo permeability transition, a catastrophic event often leading to cell death. This finding provides a potential mechanism for the cardioprotective effect of DHA. Interestingly, other n-3 PUFAs that modify membrane composition to a lesser extent have substantially less of an effect on mitochondria and do not appear to directly protect the heart. SUMMARY: Current data support a role for n-3 PUFA supplementation, particularly DHA, on mitochondria that are strongly associated with changes in mitochondrial phospholipid composition.
4 Originating Grant
-
1.
STANLEY, WILLIAM C
Docosahexaenoic Acid for Treatment of Heart Failure
1 April 2010 - 31 March 2012
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
-
2.
STANLEY, WILLIAM C
Cardiac Energy Metabolism in Heart Failure
15 July 2003 - 31 July 2014
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
-
3.
STANLEY, WILLIAM C
Training Grant in Cardiac and Vascular Cell Biology
1 April 2003 - 31 July 2014
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
-
4.
Pallone, Thomas L
Training Grant in Cardiac and Vascular Cell Biology
1 April 2003 - 31 March 2008
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2009Karen M O'Shea; Ramzi J Khairallah; Genevieve C Sparagna; Wenhong Xu; Peter A Hecker; Isabelle Robillard-Frayne; Christine Des Rosiers; Tibor Kristian; Robert C Murphy; Gary Fiskum; et al.
Journal of molecular and cellular cardiology 2009;47(6):819-27. -
2.
2012Ramzi J Khairallah; Junhwan Kim; Karen M O'Shea; Kelly A O'Connell; Bethany H Brown; Tatiana Galvao; Caroline Daneault; Christine Des Rosiers; Brian M Polster; Charles L Hoppel; et al.
PloS one 2012;7(3):e34402. -
3.
2010Ramzi J Khairallah; Karen M O'Shea; Bethany H Brown; Nishanth Khanna; Christine Des Rosiers; William C Stanley
The Journal of pharmacology and experimental therapeutics 2010;335(1):155-62.

Appears in this Publication









